This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of London. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Anne-Sophie Thorup: Innovator in Cartilage Treatment
Introduction
Anne-Sophie Thorup is a notable inventor based in London, GB. She has made significant contributions to the field of biomedical research, particularly in the development of treatments aimed at preventing cartilage loss. Her work stands out not only for its scientific merit but also for its potential therapeutic benefits.
Latest Patents
Anne-Sophie holds one patent titled “ROR2 inhibitors and use thereof in treating and/or preventing cartilage loss.” This invention pertains to anti-ROR2 inhibitors that may be utilized in the treatment of cartilage loss, addressing a crucial area of concern in medical therapies.
Career Highlights
Anne-Sophie Thorup is affiliated with Queen Mary University of London, where she engages in cutting-edge research that bridges the gap between basic science and clinical applications. Her role at the university allows her to contribute to academia while fostering innovation in her field.
Collaborations
In her research endeavors, Anne-Sophie collaborates with Francesco Dell'Accio, a distinguished colleague in the field. Their partnership exemplifies the collaborative spirit essential for driving forward advancements in medical treatments.
Conclusion
Anne-Sophie Thorup’s innovative work represents a significant stride in the area of cartilage-related therapies. Her dedication to research at Queen Mary University of London and her patent for ROR2 inhibitors highlight her contributions as an inventor committed to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile